DIAGN MICROBIOL INFECT DIS 367 1986;4:367-369

Subject Index to Volume 4

Page numbers followed by (S) refer to articles in the Supplement to Volume 4, Number 3.

Acquired immunodeficiency syndrome, 71

Acute leukemia, 65 Acute respiratory disease, 17S Adolescent population, 181 Agglutination assays, 54S Aminoglycosides, 154

antibiotics, 153 Amoxicillin, 37 Ampicillin, 155 Anaerobic bacteria, 341,359 Antibiotic, 54

resistance, 153 therapy, 65 associated gastroenteritis, 79S, 87S

Antibiotics, 139 Antibody tests, 127 Antigen, 126 Antigen detection, 5S, 9S, 24S, 47S,

94S, 113S, 162S by radioimmunoassay, 198 by tissue culture isolation, 19S diagnosis of bacterial pneumonias,

35S prognostic assessment, 35S

Antimicrobial agents, 315,342 susceptibility, 196, 224, 267 activity, 223 resistance, 95

API Staph-Ident system, 30 Automated differential instrumentation,

173

Bacterial meningitis, 161S Bacteriuria, 355 Bacteroides fragilis; 113,247 Bay n 7133, 83 Bile-esculin, 43

agar, 49 Bioluminescent

assay, 2 screening, 6 urines, 1

[3-Lactamase, 77, 93, 95, 104,105, 153 stability, 223,224, 228

Blastomyces dermatitidis, 215

Blood agar plate cultures, 9S culture detection, 122S culture systems, 351 lymphocytes, 203 supplemented media, 345

Blood parasites, 173 Boiled blood, 122 Branhamella catarrhalis, 191

Campylobacter jejuni, 71S Candida albicans, 83 Carbenicillin, 155 Cefaclor, 37 Cefoperazone, 345 Cefotaxime, 119

metabolism, 121,345 Cefotetan, 359 Cefoxitin, 247 Cefpiramide, 77 Cefpirome, 53,345 Cell cultures, 148 Cephalosporins, 157 Cerebrospinal fluid, 123S Chlamydia trachomatis infections, 93S,

102S Chronic peritoneal dialysis, 161 Circulating immune complexes, 41S Clavulanic acid, 37 Clindamycin, 133,247 Clinical features of

postanginal sepsis, 20 Clinical isolates, 95

of Haemophilus influenzae, 97 Clostridium difficile, 79S, 87S Clostridium perfringens

detection of, 307 Coagulase-negative staphylococci, 29 Coagulation factors, 37S Complement

studies, 36S fixation, 287 tests, 139,140

Corynebacterium pseudodiphtheriticum, 165

Coxiella burnetii, 125 Culture media, 241

368 Subject Index to Volume 4

Deacetylation reaction, 119 Deoxyribonucleic acid

probe, 102S hybridization, 102S

Desacetylcefotaxime, 121 Diagnosis-related groups, 135S Diagnostic methodology, 135S, 143S Dipstick tests, 15 Direct microscopic tests, 121S Disk diffusion, 345

EDTA, 122 Electron microscopy, 36S ELISA, 54S, 307 Enteric pathogens, 277

identification of, 278 Enterobacteriaceoe, 77, 79 Enterotoxin

in culture supernants, 310 in stool specimens, 310

Enteroviruses, 327 Erythyromycin, 37 Esculin hydrolysis, 49 Exoantigens, 215

extraction of, 216 interpretation of, 217 performance of, 217

Extracellular slime, 336

Flavobacterium meningosepticum, 65 Fluorescent microscopy, 36S

Genital herpes, 112S Gram-negative

bacilli, 77, 153 bacteria, 53

Gram-positive bacteria, 53 cocci, 43,115

Group A streptococci, 291 Growth phase, 83

Haemophilus ducreyi, 241 Haemophi|us influenzae, 37, 93, 95,

161S Hemolysis

concentration, 121 experiments, 120

Hemolyzed blood, 119 Hepatobiliary abnormalities, 19 Herpes simplex virus, 111S

isolation, 147 High pressure liquid chromatography,

120 Histoplasma capsulatum, 215 Human sera, 139, 167 Hydrolysis test, 43

Identification methods, 44 Imipenem, 157 Immune complex nephritis, 42S Immunoassays, 61S, 307 Immunoenzymatic test, 125 Immunofluorescent antibody, 125 Indirect immunofluorescent antibody,

127, 285 Influenza A virus, 26S, 231 Intravascular catheters, 299 In vitro

activity, 77,315 of cefpirome, 53

evaluation, 133

Keto-carboxylic acid, 315 Kinetics of cefotaxime, 121 Kirby-Bauer susceptibility testing, 11

Latex particle agglutination, 161S Leukocyte esterase, 181 LN strip test, 355 L-pyrrolidonyl-[3-naphthylamide, 43 LUMAC, 1 Lymphocytes, 205

isolation of, 205 in vitro function, 205

Measels-specific immunoglobulins, 285 Medicare/Medicaid reimbursement, 143S Miconazole, 83 Minimal bactericidal concentration, 134 Minimal inhibitory concentration, 134 Monoclonal antibodies, 55S MONOLIGHT, 1 MRC-5 cell cultures, 147 Mycobacterium avium-intracellulare, 351 Mycobacterium fortuitum, 161 Mycoplasma pneumoniae, 139 MYCOPLASMELISA, 139

Naladixic acid, 155 Nasopharyngeal secretions, 87 Neisseria gonorrhoeae, 93S, 102S Neisseria meningitidis, 259 Neutrophil, 335 Nitrite test, 181 Nucleic acid

probes, 101S hybridization, 71S, 327

Oligonucleotide mapping, 231 Oxacillin, 133

Patient management, 27S, 157S Pediatric

population, 181 urine specimens, 11

Subject Index to Volume 4 369

Penicillins, 155 Peptococcaceae bacteremia, 109 Pericarditis, 259 Peripheral blood mononuclear cells,

203 Peritonitis, 161 Plasmid fingerprinting, 71 Pneumocystis carinii, 71 Pneumonia, 165 Postanginal sepsis, 19 Primary rabbit kidney cell cultures, 147 Prophylatic measures, 24S

Q-fever, 125

Rapid diagnosis, 17S, 18S, 47S, 185 tests, 111S, 121S, 129S, 151S results, 157S detection

of bacterial diarrheas, 129S of respiratory infections, 128S

identification of coxsackie B viruses, 327

Rapid identification, 12 Rapid screening, 11 Replica plating, 32 Respiratory

virus infections, 17S, 128S syncytial virus, 25S

Rifampin, 65,133 Rotavirus, 87 Rotazyme kit, 87 Routine culture procedure, 12

Salmonella, 277 Salmonella infection, 71 Salmonella typhimurium, 71 SCH 34343, 341

Screening tests, 121S Semiquantitative cultures, 299 Sera, 126 Serodiagnosis, 142 Serology, 243 Serum-free medium, 203 Sexually transmitted agents, 101S, 185 Standard diagnostic tests, 48S, 50S Staphylococcus aureus, 133,161 Staphylococcus epidermidis, 335

isolation, 29, 31 identification, 29 characterization, 29

Streptococcal Fc receptors, 177 Streptococcal pharyngitis, 5S Streptococcal sacroiliitis, 255 Susceptibility

tests, 54, 93,317 procedures, 12, 38 of Haemophilus influenzae, 37

Symptomatic pharyngitis, 177

Therapeutic measures, 24S Throat swabs, 8S Thrombocytosis, 89 Trimethoprirrdsulfamethoxazole, 37

Upper respiratory tract infections, 87 Urine

specimens, 12,181 cultures, 357

Vancomycin, 133 Vibrio vulnificus, 49 Viral

respiratory infections, 23S enteric pathogens, 61S, 71S antibody complexes, 328 ribonucleic acid, 231